PASSERI DANIEL R 4
4 · Cue Biopharma, Inc. · Filed Apr 4, 2022
Insider Transaction Report
Form 4
PASSERI DANIEL R
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Gift
Common Stock
2022-03-31−10,000→ 131,578 total - Exercise/Conversion
Common Stock
2022-03-31+75,000→ 173,700 total - Tax Payment
Common Stock
2022-03-31$4.88/sh−32,122$156,755→ 141,578 total - Exercise/Conversion
Restricted Stock Units
2022-03-31−75,000→ 0 total→ Common Stock (75,000 underlying)
Footnotes (3)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]Each restricted stock unit award represents a contingent right to receive one share of common stock.
- [F3]One half of the Restricted Stock Units vested on September 30, 2021 and the balance vested on March 31, 2022.